Gene Targeting Core

$374,558P01FY2013HLNIH

Beth Israel Deaconess Medical Center, Boston MA

Investigators

Linked publications, trials & patents

Paper 32673514 Paper 26744078 Paper 26549640 Paper 26404488 Paper 26203857 Paper 26059452 Paper 25408699 Paper 25172498 Paper 25009290 Paper 24855053 Paper 24246501 Paper 24131182 Paper 24052946 Paper 24004125 Paper 23955166 Paper 23922321 Paper 23830865 Paper 23809110 Paper 23565201 Paper 23529929 Paper 23449636 Paper 23362118 Paper 23261320 Paper 22932696 Paper 22859060 Paper 22735569 Paper 22723222 Paper 22684996 Paper 22660553 Paper 22617771 Paper 22617766 Paper 22617763 Paper 22383490 Paper 22235125 Paper 22232208 Paper 21464207 Paper 21415727 Paper 21390184 Paper 20980682 Paper 20977632 Paper 20936356 Paper 20621955 Paper 20546740 Paper 20509943 Paper 20490978 Paper 20431063 Paper 20303465 Paper 20207994 Paper 20146261 Paper 20055798 Paper 20030844 Paper 19965691 Paper 19957349 Paper 19845583 Paper 19834585 Paper 19822898 Paper 19805374 Paper 19674970 Paper 19656134 Paper 19625216 Paper 19620774 Paper 19520738 Paper 19496923 Paper 19422330 Paper 19359602 Paper 19346756 Paper 19337853 Paper 19095759 Paper 19052327 Paper 18852292 Paper 18812468 Paper 18804472 Paper 18752325 Paper 18726119 Paper 18713747 Paper 18680538 Paper 18567823 Paper 18537971 Paper 18519813 Paper 18519558 Paper 18498633 Paper 18470642 Paper 18406566 Paper 18404480 Paper 18337253 Paper 18311159 Paper 18276995 Paper 18156497 Paper 18036594 Paper 17981736 Paper 17872466 Paper 17823293 Paper 17787061 Paper 17495228 Paper 17473221 Paper 17473211 Paper 17442731 Paper 17272819 Paper 17272818 Paper 17251987

Abstract

The primary goal of the Gene Targeting core will be to make available to the investigators of individual projects all available expertise, facilities, techniques and technical support required for generating /-/p/ttargeted mice, knockout/knockin mice and BAC transgenics. In addition, the core will provide reagents and advice on how to construct plasmids for use in Hprt targeting. In the case of knockout/knockin and BAC transgenic approaches, the core will also provide technical expertise in constructing targeting vectors.

View original record on NIH RePORTER →